Insights
Search Results
Client Highlights
5.06.26
Wilson Sonsini Advises Evantic Capital on Ethos’ $22.75 Million Series A
On May 6, 2026, Ethos, a London-based AI recruitment platform, announced a $22.75 million Series A round led by a16z with participation from General Catalyst, XTX Markets, Evantic Capital, and Common Magic. Wilson Sonsini Goodrich & Rosati advised Evantic Capital on the transaction.
Client Highlights
3.25.26
Wilson Sonsini Advises Evantic on Harvey $200 Million Financing Round
On March 25, 2026, Harvey, a legal infrastructure AI platform for law firms and in-house teams, announced $200 million in new funding co-led by returning investors GIC and Sequoia. The round values Harvey at $11 billion and includes participation from existing investors Andreessen Horowitz, Coatue, Conviction Partners, Elad Gil, Evantic Capital, and Kleiner Perkins. Wilson Sonsini Goodrich & Rosati advised Evantic Capital on the transaction.
Client Highlights
3.18.26
Wilson Sonsini Advises Lead Investor Pantera Capital on Novig’s $75 Million Series B
On February 18, 2026, Novig, a peer-to-peer sports trading platform and prediction market, announced the close of a $75 million Series B round led by Pantera Capital, with participation from Multicoin Capital, Makers Fund, Edge Equity, and existing investors Forerunner, Perceptive Ventures, and NFX. The round brings Novig's total capital raised to more than $105 million. Wilson Sonsini Goodrich & Rosati advised Pantera Capital on the transaction.
Client Highlights
2.10.26
Firm Advises IVP as Lead Investor in Solace Health’s $130 Million Series C
On February 10, 2026, Solace Health announced a $130 million Series C funding round led by IVP, accelerating the company’s mission to make advocacy a standard part of care for every patient in the United States. The Series C values Solace at over $1 billion and reflects growing consensus that healthcare advocacy is no longer optional as costs rise and systems fracture. Wilson Sonsini Goodrich & Rosati advised IVP on the transaction.
The round also included participation from existing investors Menlo Ventures, SignalFire, Torch Capital, Inspired Capital, and RiverPark Ventures. With this funding, Solace will significantly expand its national network of more than 2,000 experienced advocates serving Medicare and Medicare Advantage members, while accelerating investment in its platform and clinical research. The company will also deepen partnerships with payers and providers to embed advocacy earlier in the care journey where outcomes are most at risk.
The Wilson Sonsini team that advised IVP on the transaction included Becki DeGraw, Madeleine Vella, Andrea Linna, Nawa Lodin, Chris Paniewski, Isabel Annino, and Daniel Chen.
For more information, please see Solace Health’s news release. Additional coverage is available on Fierce Healthcare and MedCity News.
The round also included participation from existing investors Menlo Ventures, SignalFire, Torch Capital, Inspired Capital, and RiverPark Ventures. With this funding, Solace will significantly expand its national network of more than 2,000 experienced advocates serving Medicare and Medicare Advantage members, while accelerating investment in its platform and clinical research. The company will also deepen partnerships with payers and providers to embed advocacy earlier in the care journey where outcomes are most at risk.
The Wilson Sonsini team that advised IVP on the transaction included Becki DeGraw, Madeleine Vella, Andrea Linna, Nawa Lodin, Chris Paniewski, Isabel Annino, and Daniel Chen.
For more information, please see Solace Health’s news release. Additional coverage is available on Fierce Healthcare and MedCity News.
Client Highlights
1.28.26
Firm Advises Lead Investor G2 Venture Partners on Waabi’s $1 Billion Fundraise
On January 28, 2026, Waabi, the leader in Physical AI, announced it has closed its oversubscribed $750 million Series C financing round co-led by G2 Venture Partners and Khosla Ventures, and secured an additional milestone-based future investment from Uber to support a new partnership to deploy robotaxis powered by the Waabi Driver exclusively on the Uber platform. The funding, the largest fundraise in Canadian history, will fuel the continued advancement of Waabi’s Physical AI Platform, further accelerate the company’s commercial progress in autonomous trucking, and support Waabi’s expansion into robotaxis. Wilson Sonsini Goodrich & Rosati advised G2 Venture Partners on the transaction.
The Wilson Sonsini team that advised G2 Venture Partners included Danielle Naftulin, Madeleine Vella, Rodrigo Valle, and Tori Fong.
For more information, please see Waabi’s announcement.
The Wilson Sonsini team that advised G2 Venture Partners included Danielle Naftulin, Madeleine Vella, Rodrigo Valle, and Tori Fong.
For more information, please see Waabi’s announcement.